5PSQ-075 Fingolimod-associated lymphopaenia in multiple sclerosis patients

BACKGROUND: Fingolimod changes lymphocyte count. PURPOSE: To evaluate changes in lymphocyte count and infection incidence in patients with multiple sclerosis (MS) receiving fingolimod. MATERIAL AND METHODS: Retrospective study that included all fingolimod-treated patients in a tertiary hospital. Pat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Autores principales: Navarro, M, Betancor, T, Diaz, P, Calzado, G, Ramos, E, Suárez, M, Vera, M, Plasencia, I, Ferrer, A, Merino, J
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2018
Materias:
Section 5: Patient safety and quality assurance
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535408/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.429
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares